LUMA Partners
Overview
LUMA Partners is an investment bank and strategic advisory firm that focuses on the digital media, adtech, and martech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Character Biosciences | Mar 2025 | Series B | Lead |
| Curve Biosciences | Oct 2025 | Series A | Lead |
| ArsenalBio | Sep 2024 | Series C | Co-investor |
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
James Kasuboski
Co-Founder
Negin Mokhtari
Venture Partner (Luma Group) & Chief Strategy Officer (LABI)
Matteo Gallo
Investor Board Member (SEI Fund)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LUMA Partners based?
LUMA Partners is headquartered in New York City, New York, United States.
When was LUMA Partners founded?
LUMA Partners was founded in 2010.
How many portfolio companies does LUMA Partners have?
LUMA Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in LUMA Partners's portfolio?
Portfolio companies visible on Caplight include Character Biosciences, Curve Biosciences, ArsenalBio, Aeovian Pharmaceuticals.
What was LUMA Partners's most recent investment shown here?
LUMA Partners's most recent investment in this portfolio sample was in Aeovian Pharmaceuticals in 2025.
What sectors does LUMA Partners focus on?
LUMA Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does LUMA Partners focus on?
LUMA Partners typically invests at the Mid stage.